Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
about
How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizationsModelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings.Economic evaluations of neuraminidase inhibitors to control influenza.Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision.Audit of the use of antimicrobial prophylaxis in nasal surgery at a specialist Australian hospital.Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use
P2860
Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Superbugs II: how should econo ...... tain antimicrobial resistance?
@en
type
label
Superbugs II: how should econo ...... tain antimicrobial resistance?
@en
prefLabel
Superbugs II: how should econo ...... tain antimicrobial resistance?
@en
P2093
P2860
P356
P1433
P1476
Superbugs II: how should econo ...... tain antimicrobial resistance?
@en
P2093
Anne-Marie Karcher
Michael Millar
Paula Wilton
Richard Smith
P2860
P304
P356
10.1002/HEC.693
P407
P50
P577
2002-10-01T00:00:00Z